It will be 250 years since the founding of a separate Chair of Materia Medica in Edinburgh, probably the first chair of what would become pharmacology in the world. This rich history of Edinburgh Pharmacology is being celebrated with a meeting on Pharmacology's Future, one that highlights the importance of pharmacology in scientific discovery, the creation of new medicines, and in understanding and minimising toxicity. Hosted by Edinburgh's Pharmacology Community, this meeting will showcase world-class pharmacology from both the UK and across the globe and will be of particular interest to researchers from across science and medicine.
Pharmacology Futures 2018 will explore the technologies that will drive drug development over the next 10 to 15 years, with speakers sharing their visions of the future to celebrate 250 years of pharmacology in Edinburgh.
The University of Edinburgh's Cameron Prize for Therapeutics will also be awarded during the meeting.
To explore the technologies that will drive drug development over the next 10 to 15 years.
To understand the role of structural genomics in generating and testing small molecule inhibitors
To appreciate the importance of epigenetics as a target for drug discovery
To recognise the role of stem cells in therapeutics, drug safety pharmacology, and drug discovery
To appreciate the use of biomarkers in guiding therapy
To understand the importance of allosteric drug binding sites for novel drug development
To describe trans-institute approaches to drug development for neurological diseases, using the NIMH as an example.
A conference dinner will follow the event, with tickets available to buy when registering online.